Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.005 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |